XDH and chronic kidney disease: Figure 2 depicts the cumulative incidence of CKD in patients receiving XO inhibitors, uricosuric agents, both, and those not receiving any ULT with the Kaplan-Meier curve, and the p value of the log-rank test was found to be 0.085.